DOI: 10.1007/s11095-009-0045-6 United States Pharmacopeia
The American Diabetes Association (2022) reports that GLP-1 receptor agonists reduce HbA1c by 1.01.8% and systolic blood pressure by 23 mmHg alongside weight reduction
In this period, 99.7% of the selected patients completed the study, 84.7% in the oral semaglutide arm, and 90.1% in the placebo arm [44]
KFF data showed two-thirds of state Medicaid programs said cost was a decision factor when determining coverage of GLP-1 drugs
In the CY 2024 OPPS/ASC final rule with comment period, based on hospital statements that many hospitals could not calculate a payer-specific negotiated charge as their payer-specific negotiated charge was based on a percentage of billed charges or based on a formula or algorithm that may be determined after the episode of care, we finalized new data elements, the payer-specific negotiated charge percentage and the payer-specific negotiated charge algorithm, to provide MRF users with an understanding of how the payer-specific negotiated charge was calculated, and a contextual data element, the estimated allowed amount, which is a dollar amount reflecting the average of the historical reimbursement (allowed amount) received from a third party payer for an item or service, required to be displayed when no payer-specific negotiated charge dollar can be encoded
This makes the BPC spray great for researchers who value accuracy and simplicity
